Alle verbonden artikelen

Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?

Auteurs : Paesmans M
Jaar : 2015
Journal : Eur Respir J
Volume : 46
Pagina's : 1259-61

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Najar M, Stamatopoulos B, Pieters K, Pradier O, Bron D, Meuleman N, Lagneaux L
Jaar : 2015
Journal : Cancer Immunol Immunother
Volume : 64(2)
Pagina's : 213-24

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Auteurs : Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart M, Michiels S, Bradbury I, Sotiriou C, Loi S
Jaar : 2015
Journal : JAMA Oncol
Volume : 1(4)
Pagina's : 448-54

A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres : The QUEST Phantom Study.(103 collaborators : for Institut Bordet : B. Vanderlinden and P. Flamen)

Auteurs : Willowson KP, Tapner M, Bailey DL, + collaborators (among others :, Flamen P, Vanderlinden B
Jaar : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42
Pagina's : 1202-22

Colorectal cancer: ten years of illusion of progress but advances are on the horizon].

Auteurs : Shaza L, Charette N, Hendlisz A
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 263-6

Prognosis of neutropenic patients admitted to the intensive care unit.

Auteurs : Mokart D, Darmon M, Resche-Rigon M, Lemiale V, Pène F, Mayaux J, Rabbat A, Kouatchet A, Vincent F, Nyunga M, Bruneel F, Lebert C, Perez P, Renault A, Hamidfar R, Jourdain M, Meert AP, Benoit D, Chevret S, Azoulay E
Jaar : 2015
Journal : Intensive Care Med
Volume : 41(2)
Pagina's : 296-303

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

Auteurs : Zardavas D, Fouad TM, Piccart-Gebhart M
Jaar : 2015
Journal : Breast
Volume : 24 Suppl 2
Pagina's : S143-8

Towards tuberculosis elimination: an action framework for low-incidence countries.

Auteurs : Lönnroth K, Migliori GB, Abubakar I, + collaborators (among others :, Sculier JP, Raviglione MC
Jaar : 2015
Journal : Eur. Respir. J.
Volume : 45(4)
Pagina's : 928-52

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

Auteurs : Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EG, Piccart-Gebhart M
Jaar : 2015
Journal : Ann Oncol
Volume : 26
Pagina's : 1547-73

Targeted therapy for lung cancer.

Auteurs : Meert AP, Cadranel J
Jaar : 2015
Journal : Eur Respir J
Volume : 46
Pagina's : 1239-41

Myelofibrosis patients in Belgium: disease characteristics.

Auteurs : Devos T, Zachée P, Bron D, Noens L, Droogenbroeck JV, Mineur P, Beguin Y, Berneman Z, Benghiat FS, Kentos A, Chatelain C, Demuynck H, Lemmens J, Eygen KV, Theunissen K, Trullemans F, Pierre P, Pluymers W, Knoops L
Jaar : 2015
Journal : Acta Clin Belg
Volume : 70(2)
Pagina's : 105-11

Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology.

Auteurs : Albisinni S, Rassweiler J, Abbou C, Cathelineau X, Chlosta P, Fossion L, Gaboardi F, Rimington P, Salomon L, Sanchez-Salas R, Stolzenburg J, Teber D, Van Velthoven R
Jaar : 2015
Journal : BJU Int
Volume : 115(6)
Pagina's : 937-45

Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue.

Auteurs : Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L
Jaar : 2015
Journal : Stem Cells Dev.
Volume : 24(18)
Pagina's : 2142-57

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.

Auteurs : Azim HA, Peccatori FA, Brohée S, Branstetter D, Loi S, Viale G, Piccart-Gebhart M, Dougall WC, Pruneri G, Sotiriou C
Jaar : 2015
Journal : Breast Cancer Res
Volume : 17
Pagina's : 24

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.

Auteurs : Ignatiadis M, Lee M, Jeffrey SS
Jaar : 2015
Journal : Clin Cancer Res
Volume : 21
Pagina's : 4786-800

Intraperitoneal follicular dendritic cell sarcoma: role of chemotherapy and bone marrow allotransplantation in locally advanced disease?

Auteurs : Liberale G, Keriakos K, Azerad M, de Saint-Aubain de Somerhausen N, El Nakadi I
Jaar : 2015
Journal : Clin Med Insights Oncol
Volume : 9
Pagina's : 9-13

Evaluation of a new standardized enzymatic isolation protocol for human umbilical cord-derived stem cells.

Auteurs : Buyl K, Vanhaecke T, Desmae T, Lagneaux L, Rogiers V, Najar M, De Kock J
Jaar : 2015
Journal : Toxicol In Vitro
Volume : 29(6)
Pagina's : 1254-62.

ESR/ERS white paper on lung cancer screening.

Auteurs : Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP
Jaar : 2015
Journal : Eur. Respir. J.
Volume : 46(1)
Pagina's : 28-39

Health impacts of anthropogenic biomass burning in the developed world.

Auteurs : Sigsgaard T, Forsberg B, Annesi-Maesano I, Blomberg A, Bølling A, Boman C, Bønløkke J, Brauer M, Bruce N, Héroux ME, Hirvonen MR, Kelly F, Künzli N, Lundbäck B, Moshammer H, Noonan C, Pagels J, Sallsten G, Sculier JP, Brunekreef B
Jaar : 2015
Journal : Eur Respir J
Volume : 46
Pagina's : 1577-88

Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations.

Auteurs : Berghmans T, Meert AP, Quoix E
Jaar : 2015
Journal : Eur. Respir. J.
Volume : 46(1)
Pagina's : 19-21